A new trading day began on Monday, with Annovis Bio Inc (NYSE: ANVS) stock price up 10.59% from the previous day of trading, before settling in for the closing price of $2.55. ANVS’s price has ranged from $1.11 to $10.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -73.95% over the past five years. Meanwhile, its annual earnings per share averaged 40.69%. With a float of $16.62 million, this company’s outstanding shares have now reached $19.49 million.
Let’s look at the performance matrix of the company that is accounted for 8 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Annovis Bio Inc (ANVS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Annovis Bio Inc is 14.70%, while institutional ownership is 15.85%.
Annovis Bio Inc (ANVS) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.44 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.87% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Here are Annovis Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.21, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
Annovis Bio Inc (NYSE: ANVS) saw its 5-day average volume 0.24 million, a negative change from its year-to-date volume of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 49.84%.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 72.15%, which indicates a significant increase from 71.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.68, while its 200-day Moving Average is $3.60. Nevertheless, the first resistance level for the watch stands at $2.99 in the near term. At $3.17, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.39. If the price goes on to break the first support level at $2.60, it is likely to go to the next support level at $2.38. Assuming the price breaks the second support level, the third support level stands at $2.21.
Annovis Bio Inc (NYSE: ANVS) Key Stats
With a market capitalization of 54.95 million, the company has a total of 19,486K Shares Outstanding. Currently, annual sales are 0 K while annual income is -24,590 K. The company’s previous quarter sales were 0 K while its latest quarter income was -5,540 K.
